Search

everythinglearnresearchcommunity

for

Search:↓

Storing nanofat at -20°C for 7 days does not harm its ability to regenerate.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Stem cell niches are crucial for regulating stem cell behavior and tissue health, and their decline can impact aging and cancer.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Ozone therapy might improve cancer treatment and reduce its side effects.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Stem cell research and regenerative medicine have made significant advancements in treating various diseases and conditions.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Ovarian drilling surgery is not clearly better than medical treatments for PCOS symptoms.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Hair loss in postmenopausal woman caused by ovarian issue.

Ketoconazole can treat ovarian hyperandrogenism but should be used cautiously with monitoring and birth control.